Figure 3From: In vivo Molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging systemThe antibody activity of anti-Sp17-ICG-Der-02 tested with ELISA. A. naked anti-Sp17 antibody; B. anti-Sp17-ICG-Der-02 conjugate.Back to article page